A Message from Andrew Cleeland, CEO of the Fogarty Institute, on Diversity
Click here to read the message
At the Fogarty Institute, we believe innovation is the lifeblood of medical advancement. This conviction drives our seasoned team as we seek unique pathways to bring life-changing medical therapies to market faster. Dr. Thomas J. Fogarty, one of the most noted cardiovascular surgeons and innovators of all time, founded the Institute with the vision of improving patients’ lives while lowering healthcare costs. As an educational nonprofit, we are uniquely positioned to expand on this goal through our programs that cultivate innovators, accelerate the development of their ideas and elevate the global medtech ecosystem.
We learn best by doing.
Focusing on Patients
Our core mission is simple: to improve the well-being of patients and their families wherever they may live.
Cultivating the Innovator
We nurture future entrepreneurs through robust educational and mentorship programs.
Accelerating the Therapy
Our programs and collaborations help us advance promising therapies so they can get to market and patients faster.
Elevating the Ecosystem
By bringing together the innovation ecosystem, we help shape global policy and regulation through informed advocacy and find new ways for interested parties to collaborate in advancing medical innovation.
Since our inception, we have mentored hundreds of entrepreneurs, government officials, corporate and healthcare partners, and future innovators.
Our strategic partnerships make our success possible.
Thanks to the Institute’s proximity to El Camino Hospital, our medtech startups can identify and solve real clinical needs, while having access to world-class nurses, technicians and physicians who work on healthcare challenges daily and can provide instant feedback on what works and what doesn’t.
Companies-in-residence also can conduct clinical research that fine-tunes their solutions.
These opportunities for collaboration ultimately create more effective devices and solutions.
The Fogarty Institute has enjoyed a long-standing relationship with Stanford Biodesign, an esteemed program aimed at advancing healthtech innovation.
Our roots are deep and intertwined: Many of our companies stem from Stanford Biodesign, and their students regularly visit to learn from the early-stage startups and our graduates.
Our staff and board members are part of their mentoring team, and our entrepreneurs benefit from interacting with their world-class experts.
As an incubator of carefully selected medtech companies, we offer our corporate partners a unique view into the startup culture, which gives them an opportunity to learn first-hand how to apply our spirit of innovation domestically and abroad.
We offer partner teams an opportunity to co-locate with our startups in an entrepreneurial setting.
At the Fogarty Institute, we know that breakthroughs occur when we learn from each other.
Underscoring our belief that working together yields better solutions, we have formed strong collaborations with other like-minded organizations focused on medtech advancement.
Our team and entrepreneurs frequently speak at universities, participate in industry-leading events, and engage in discussions with a variety of global companies and hospital administrators to help advance our industry.
We plan to expand our collaborations in an effort to broaden our impact and help elevate the medtech ecosystem as a whole.